ANGLIA RUSKIN UNIVERSITY New research has found that patients’ self-management of their diabetes has suffered during the COVID-19 pandemic, particularly during periods of self-isolation. A study led by Anglia Ruskin University (ARU), published in the journal Diabetology and Metabolic Syndrome, surveyed 679 adult patients between May and November 2020 and found that self-isolation was associated...
Category: <span>Diabetes</span>
Post
Isolation severely impacts diabetes management
New research has found that patients’ self-management of their diabetes has suffered during the COVID-19 pandemic, particularly during periods of self-isolation. A study led by Anglia Ruskin University (ARU), published in the journal Diabetology and Metabolic Syndrome, surveyed 679 adult patients between May and November 2020 and found that self-isolation was associated with greater fluctuations of blood glucose levels,...
Post
Long-term, low-dose aspirin did not affect risk of dementia in adults with type 2 diabetes
AMERICAN HEART ASSOCIATION DALLAS, Nov. 15, 2021 — Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline among adults with type 2 diabetes, according to late-breaking research presented today at the American Heart Association’s Scientific Sessions 2021. The meeting is fully virtual, Saturday, November 13-Monday, November 15,...
Post
Signaling molecules called EETs may improve treatment for insulin resistance
by Bill Snyder, Vanderbilt University Medical Center Credit: CC0 Public Domain Analogs of signaling molecules called EETs may improve treatment of insulin resistance, a primary risk factor for development of Type 2 diabetes and cardiovascular disease, according to a new paper by researchers at Vanderbilt University Medical Center. Ambra Pozzi, Ph.D., and colleagues previously reported that EETs...
Post
New biomarkers for type 1 diabetes identified
by University of Montreal Credit: CC0 Public Domain A research team led by Dr. Despoina Manousaki of the CHU Sainte-Justine Research Centre and the Université de Montréal has identified three circulating proteins as promising molecules for the development of drugs and early detection tools for patients with type 1 diabetes. Type 1 diabetes is an...
Post
Blood biomarker identified that predicts type 2 diabetes many years before diagnosis
by Lund University Fig. 1: Kaplan–Meier curve to illustrate incidence of diabetes in relation to follistatin quartiles. Time axis was follow-up time until death, emigration, incident diabetes or end of follow-up (n = 4195; p = 1.01E-7; two-sided log-rank test). Credit: DOI: 10.1038/s41467-021-26536-w A large study led by Lund University in Sweden has identified a protein in the blood...
Post
Dexamethasone effectively reduces COVID-19 deaths but potential diabetic-like complications should be monitored
SOCIETY FOR ENDOCRINOLOGY Use of the steroid, dexamethasone, has been confirmed as a reliable and effective treatment for COVID-19, even in patients with diabetes, according to research to be presented at the Society for Endocrinology annual conference in Edinburgh. By the second wave of the pandemic, dexamethasone was routinely being used to treat hospitalised patients...
Post
Reversing new-onset type 1 diabetes with pyramid-like DNA
by American Chemical Society Drawing of tetrahedral framework nucleic acids, which reversed new-onset type 1 diabetes in mice. Credit: Adapted from ACS Applied Materials & Interfaces Usually diagnosed in children, teens and young adults, type 1 diabetes is an autoimmune disease in which the immune system attacks and destroys insulin-secreting β-cells in the pancreas. As...
Post
Lack of important molecule in red blood cells causes vascular damage in type 2 diabetes
Altered function of the red blood cells leads to vascular damage in type 2 diabetes. Results from a new study in cells from patients with type 2 diabetes and mice show that this effect is caused by low levels of an important molecule in the red blood cells. The study by researchers at Karolinska Institutet...
Post
Retrospective study finds that cancer drug also lowers blood glucose
by Mayo Clinic Credit: Pixabay/CC0 Public Domain Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used to treat diabetes, and with more research may become a novel therapy for diabetic patients, according to new research published in Mayo Clinic Proceedings. Dasatinib is a tyrosine kinase...